Amgen Balance Sheet Health

Financial Health criteria checks 1/6

Amgen has a total shareholder equity of $6.2B and total debt of $64.6B, which brings its debt-to-equity ratio to 1036.8%. Its total assets and total liabilities are $97.2B and $90.9B respectively. Amgen's EBIT is $8.2B making its interest coverage ratio 2.8. It has cash and short-term investments of $10.9B.

Key information

1,036.8%

Debt to equity ratio

US$64.61b

Debt

Interest coverage ratio2.8x
CashUS$10.94b
EquityUS$6.23b
Total liabilitiesUS$90.92b
Total assetsUS$97.15b

Recent financial health updates

Recent updates

Amgen: The Giant With An Impressive Pipeline

Apr 15

Is Amgen (NASDAQ:AMGN) Using Too Much Debt?

Apr 01
Is Amgen (NASDAQ:AMGN) Using Too Much Debt?

Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock

Mar 31

Amgen Will Benefit From Increased Medical Spending

Mar 12

Amgen: A Good Dividend Growth Stock For The Watch List

Mar 04

Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit

Feb 21
Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit

Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now

Feb 16
Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now

Amgen: Weight Loss Drug Candidate Debate A Red Herring - Buying The Dip Advisable

Feb 08

Amgen: Accelerating The Business And Dividend Growth

Jan 29

Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?

Jan 29
Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?

Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks

Jan 22

Is Amgen (NASDAQ:AMGN) A Risky Investment?

Dec 28
Is Amgen (NASDAQ:AMGN) A Risky Investment?

Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors

Dec 13
Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors

Are Investors Undervaluing Amgen Inc. (NASDAQ:AMGN) By 46%?

Oct 23
Are Investors Undervaluing Amgen Inc. (NASDAQ:AMGN) By 46%?

Is Amgen (NASDAQ:AMGN) Using Too Much Debt?

Sep 22
Is Amgen (NASDAQ:AMGN) Using Too Much Debt?

Do Amgen's (NASDAQ:AMGN) Earnings Warrant Your Attention?

Sep 04
Do Amgen's (NASDAQ:AMGN) Earnings Warrant Your Attention?

Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13

Aug 05
Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13

Amgen Inc. (NASDAQ:AMGN) Shares Could Be 45% Below Their Intrinsic Value Estimate

May 30
Amgen Inc. (NASDAQ:AMGN) Shares Could Be 45% Below Their Intrinsic Value Estimate

Amgen (NASDAQ:AMGN) Is Paying Out A Larger Dividend Than Last Year

May 09
Amgen (NASDAQ:AMGN) Is Paying Out A Larger Dividend Than Last Year

These 4 Measures Indicate That Amgen (NASDAQ:AMGN) Is Using Debt Reasonably Well

Apr 29
These 4 Measures Indicate That Amgen (NASDAQ:AMGN) Is Using Debt Reasonably Well

Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13

Apr 05
Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13

Amgen Inc. (NASDAQ:AMGN) Shares Could Be 37% Below Their Intrinsic Value Estimate

Feb 27
Amgen Inc. (NASDAQ:AMGN) Shares Could Be 37% Below Their Intrinsic Value Estimate

Financial Position Analysis

Short Term Liabilities: AMGN's short term assets ($30.3B) exceed its short term liabilities ($18.4B).

Long Term Liabilities: AMGN's short term assets ($30.3B) do not cover its long term liabilities ($72.5B).


Debt to Equity History and Analysis

Debt Level: AMGN's net debt to equity ratio (861.2%) is considered high.

Reducing Debt: AMGN's debt to equity ratio has increased from 271.4% to 1036.8% over the past 5 years.

Debt Coverage: AMGN's debt is not well covered by operating cash flow (13.1%).

Interest Coverage: AMGN's interest payments on its debt are not well covered by EBIT (2.8x coverage).


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.